María Ana Martinez-Castellanos

Twelve-month safety of intravitreal injections of bevacizumab (Avastin®): results of the Pan-American Collaborative Retina Study Group (PACORES)

Lihteh Wu, María Ana Martinez-Castellanos, Hugo Quiroz–Mercado et al. · Graefe s Archive for Clinical and Experimental Ophthalmology · 2007 · 457 citations

Medicine, Ophthalmology, Surgery +16

ANTIANGIOGENIC THERAPY WITH INTRAVITREAL BEVACIZUMAB FOR RETINOPATHY OF PREMATURITY

Hugo Quiroz-Mercado, María Ana Martinez-Castellanos, Myriam Lucía Hernández-Rojas et al. · Retina · 2008 · 144 citations

Medicine, Ophthalmology, Pharmacotherapy +17

LONG-TERM EFFECT OF ANTIANGIOGENIC THERAPY FOR RETINOPATHY OF PREMATURITY Up to 5 Years of Follow-up

María Ana Martinez-Castellanos, Shulamit Schwartz, Myriam Lucía Hernández-Rojas et al. · Retina · 2012 · 118 citations

Medicine, Ophthalmology, Pediatrics +13

Expert Diagnosis of Plus Disease in Retinopathy of Prematurity From Computer-Based Image Analysis

J. Peter Campbell, Esra Ataer-Cansızoğlu, Verónica Bolón‐Canedo et al. · JAMA Ophthalmology · 2016 · 117 citations · Full text

Medicine, Ophthalmology, Vision Science +17

Short-term outcome after intravitreal ranibizumab injections for the treatment of retinopathy of prematurity

María Ana Martinez-Castellanos, Shulamit Schwartz, Gerardo García‐Aguirre et al. · British Journal of Ophthalmology · 2012 · 100 citations

Medicine, Ophthalmology, Pediatrics +17